Robert Walters PLC
07 January 2008
Form TR-1 with annex. FSA Version 2.1 updated April 2007
For filings with the FSA include the annex
For filings with issuer exclude the annex
TR-1: Notifications of Major Interests in Shares
1. Identity of the issuer or the underlying issuer Robert Walters PLC
of existing shares to which voting rights are --------------------
attached:
------------------------------
2. Reason for notification (yes/no)
------------------------------------------------
--------
An acquisition or disposal of voting rights YES
------------------------------------------ --------
An acquisition or disposal of financial instruments which may result in
the acquisition of shares already issued to which voting rights are --------
attached
------------------------------------------
An event changing the breakdown of voting rights
------------------------------------------ --------
Other (please specify):______________
------------------------------------------ --------
3. Full name of person(s) subject to Ruane, Cunniff & Goldfarb Inc.
notification obligation: ------------------------
--------------------------
4. Full name of shareholder(s) (if
different from 3): ------------------------
--------------------------
5. Date of transaction (and date on which 12/31/07
the threshold is crossed or reached if ------------------------
different):
--------------------------
6. Date on which issuer notified: 1/4/08
-------------------------- ------------------------
7. Threshold(s) that is/are crossed or
reached: 7%
-------------------------- ------------------------
8: Notified Details
A: Voting rights attached to shares
Class/type Situation previous to the Resulting situation after the triggering transaction
of shares triggering transaction
If possible
use ISIN Number of Number of Number of Number of voting Percentage of
code: shares voting shares rights voting rights
rights Direct Indirect Direct Indirect
GB0008475088 4,000,000 4,000,000 5,561,297 5,561,297 7.228%
B: Financial Instruments
Resulting situation after the triggering transaction
Type of Expiration Exercise/ No. of voting rights that may Percentage
financial date conversion be acquired (if the instrument of voting
instrument period/date exercised/converted) rights
Total (A+B)
Number of voting rights Percentage of voting rights
5,561,297 7.228%
9. Chain of controlled undertakings through which the voting rights and /or the
financial instruments are effectively held, if applicable:
Proxy Voting:
10. Name of proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:
14 Contact name: Joseph Quinones, Jr., Vice President
15. Contact telephone name: 212-832-5280 (USA)
For notes on how to complete form TR-1 please see the FSA website.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.